✦ LIBER ✦

Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients

✍ Scribed by Cesar Ramon G. Espiritu; Victor L. Caparas; Joanne G. Bolinao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of the safety of prophylactic

✍ Stephen S. Lane; Robert H. Osher; Samuel Masket; Shaleen Belani 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Aqueous penetration of moxifloxacin 0.5%

✍ Junko Yoshida; Alisa Kim; Kimberly A. Pratzer; Walter J. Stark 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Aqueous Penetration and Biological Activ

✍ Dianne H. Kim; Walter J. Stark; Terrence P. O’Brien; James D. Dick 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Prophylactic intracameral cefuroxime: Ev

✍ Per G. Montan; Gisela Wejde; Hans Setterquist; Margareta Rylander; Charlotta Zet 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Safety of besifloxacin ophthalmic suspen

✍ Jai G. Parekh; T. Hunter Newsom; Steven Nielsen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Clinical Safety of Moxifloxacin Ophthalm

✍ Lewis H. Silver; Adrienne M. Woodside; Dawnelle B. Montgomery 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 114 KB